Pharmaceutical Intermediate Ceritinib Raw Material Ceritinib Powder Ceritinib

Still deciding? Get samples of $ !
Request Sample
Product Details
Customization: Available
Powder: Yes
Customized: Customized
Diamond Member Since 2025

Suppliers with verified business licenses

Audited Supplier Audited Supplier

Audited by an independent third-party inspection agency

Fast Delivery
The supplier can deliver the goods within 15 days
Low MOQ
The MOQ for the supplier's products is 1
Customization from Samples
The supplier provides sample based customization services
QA/QC Inspectors
The supplier has 1 QA and QC inspection staff
to see all verified strength labels (6)
Pharmaceutical Intermediate Ceritinib Raw Material Ceritinib Powder Ceritinib pictures & photos
Pharmaceutical Intermediate Ceritinib Raw Material Ceritinib Powder Ceritinib pictures & photos
Pharmaceutical Intermediate Ceritinib Raw Material Ceritinib Powder Ceritinib pictures & photos
Pharmaceutical Intermediate Ceritinib Raw Material Ceritinib Powder Ceritinib pictures & photos
Pharmaceutical Intermediate Ceritinib Raw Material Ceritinib Powder Ceritinib pictures & photos
Pharmaceutical Intermediate Ceritinib Raw Material Ceritinib Powder Ceritinib pictures & photos
  • Pharmaceutical Intermediate Ceritinib Raw Material Ceritinib Powder Ceritinib
  • Pharmaceutical Intermediate Ceritinib Raw Material Ceritinib Powder Ceritinib
  • Pharmaceutical Intermediate Ceritinib Raw Material Ceritinib Powder Ceritinib
  • Pharmaceutical Intermediate Ceritinib Raw Material Ceritinib Powder Ceritinib
  • Pharmaceutical Intermediate Ceritinib Raw Material Ceritinib Powder Ceritinib
  • Pharmaceutical Intermediate Ceritinib Raw Material Ceritinib Powder Ceritinib

Find Similar Products

Overview

Basic Info.

Model NO.
CQM Ceritinib
Certification
GMP, HSE, ISO 9001, USP, BP
Suitable for
Elderly, Adult
State
Powder
Purity
>99%
Product Name
Ceritinib
Name
Ceritinib Powder
Appearance
White Powder
Color
White
Grade
Pharmaceutical Grade
Assay
HPLC 99%
Application
Pharmaceutical
Specific
COA
Test Method
HPLC
Shelf Life
2 Years
CAS No.
1032900-25-6
Mf
C28h36cln5o3s
MW
558.14
Melting Point
720.7
Density
1.251
Transport Package
Negotiable
Specification
99%
Trademark
CQM
Origin
Shaanxi Xi'an
Production Capacity
1000kg/Month

Product Description

Pharmaceutical Intermediate Ceritinib Raw Material Ceritinib Powder Ceritinib
Pharmaceutical Intermediate Ceritinib Raw Material Ceritinib Powder Ceritinib
Product Description
Pharmaceutical Intermediate Ceritinib Raw Material Ceritinib Powder Ceritinib
Pharmaceutical Intermediate Ceritinib Raw Material Ceritinib Powder Ceritinib
Product Details
Pharmaceutical Intermediate Ceritinib Raw Material Ceritinib Powder Ceritinib
Product Name
Ceritinib
CAS No.
1032900-25-6
MF
C28h36cln5o3s
MW
558.14
Appearance
White Powder
Ceritinib, with the Chemical Abstracts Service (CAS) number 1032900-25-6, is a small-molecule tyrosine kinase inhibitor that specifically targets anaplastic lymphoma kinase (ALK). It is chemically known as 5-Chloro-N2-[2-isopropoxy-5-methyl-4-(4-piperidinyl)phenyl]-N4-[2-(isopropylsulfonyl)phenyl]-2,4-pyrimidinediamine. The molecular formula of ceritinib is C28H36CIN5O3S, and it has a molecular weight of 558.14 g/mol. Ceritinib appears as a white to off-white powder with low solubility in aqueous solutions but higher solubility in organic solvents like dimethyl sulfoxide (DMSO). It is stable under standard storage conditions but should be protected from light and moisture to maintain its integrity. Ceritinib is a potent and selective inhibitor of ALK, with additional activity against factor 1 receptor (IGF-1R) and ROS1 kinase. Its mechanism of action involves binding to the ATP-binding site of ALK, thereby inhibiting its phosphorylation and downstream signaling pathways, which are critical for the survival and proliferation of cancer cells.
Application&Function
Pharmaceutical Intermediate Ceritinib Raw Material Ceritinib Powder Ceritinib
Pharmaceutical Intermediate Ceritinib Raw Material Ceritinib Powder Ceritinib
Ceritinib is primarily used in the treatment of non-small cell lung cancer (NSCLC) that is ALK-positive, as identified by FDA-approved tests. It is particularly effective in patients who have developed resistance to crizotinib, another ALK inhibitor. Ceritinib works by blocking the aberrant ALK signaling that drives tumor growth, leading to apoptosis in cancer cells. Clinical trials have demonstrated its efficacy in both treatment-naïve and crizotinib-resistant patients, with significant tumor response rates and progression-free survival benefits. The drug is administered orally, typically in the form of capsules, and is metabolized primarily by the liver via cytochrome P450 enzymes, particularly CYP3A4. Due to its potent inhibitory effects, ceritinib has also shown promise in treating other ALK-driven malignancies, such as inflammatory myofibroblastic tumors and neuroblastoma. However, its use may be associated with adverse effects, including gastrointestinal disturbances, hepatotoxicity, and cardiac issues, necessitating careful patient monitoring. Ongoing research explores its potential in combination therapies and broader oncological applications, solidifying its role as a key therapeutic agent in precision medicine for ALK-positive cancers.
Specification
Pharmaceutical Intermediate Ceritinib Raw Material Ceritinib Powder Ceritinib
Certificate of Analysis
Pharmaceutical Intermediate Ceritinib Raw Material Ceritinib Powder Ceritinib

Pharmaceutical Intermediate Ceritinib Raw Material Ceritinib Powder Ceritinib
Pharmaceutical Intermediate Ceritinib Raw Material Ceritinib Powder Ceritinib
Pharmaceutical Intermediate Ceritinib Raw Material Ceritinib Powder Ceritinib
Pharmaceutical Intermediate Ceritinib Raw Material Ceritinib Powder Ceritinib
Pharmaceutical Intermediate Ceritinib Raw Material Ceritinib Powder Ceritinib
Pharmaceutical Intermediate Ceritinib Raw Material Ceritinib Powder Ceritinib
Pharmaceutical Intermediate Ceritinib Raw Material Ceritinib Powder Ceritinib

Send your message to this supplier

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now